2022
DOI: 10.1053/j.semnuclmed.2021.06.004
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Management of COVID-19 Patients – An Update

Abstract: SARS-CoV-2 virus may cause COVID-19 disease, which causes mild-to-moderate disease in 80% of laboratory-confirmed cases have and could be community-managed. A considerable age-dependent mortality is seen among elderly and other at-risk populations but among young and healthy individuals it is < 0.5%. Long term health issues has been reported following severe COVID-19 requiring hospitalization as well as after cases of mild COVID-19 without hospitalization. Upon receiving COVID-19 suspected patients at hospital… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
36
0
5

Year Published

2022
2022
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(41 citation statements)
references
References 68 publications
0
36
0
5
Order By: Relevance
“…While these symptoms can be fatal for some, others may be completely asymptomatic [ 13 ]. Furthermore, there is increasing evidence that SARS-CoV-2 infection may cause serious long-term side effects for both hospitalized and asymptomatic individuals, such as anxiety, depression, cognitive impairment, and dyspnea [ 14 , 15 ]. The unpredictable and long-term impact of COVID-19 on the health of infected patients highlights the dire need for curative treatments and models of study.…”
Section: Introductionmentioning
confidence: 99%
“…While these symptoms can be fatal for some, others may be completely asymptomatic [ 13 ]. Furthermore, there is increasing evidence that SARS-CoV-2 infection may cause serious long-term side effects for both hospitalized and asymptomatic individuals, such as anxiety, depression, cognitive impairment, and dyspnea [ 14 , 15 ]. The unpredictable and long-term impact of COVID-19 on the health of infected patients highlights the dire need for curative treatments and models of study.…”
Section: Introductionmentioning
confidence: 99%
“…Patients with COVID-19 who have respiratory insufficiency should be closely monitored with continuous pulse oximetry [430]. Maintaining a respiratory frequency (RF) of 24/min, an oxygen saturation (SpO 2 ) between 92 and 96%, and/or a pO 2 of 8.5 kPa is the primary focus of treatment choices [432]. If the patient does not maintain these levels, oxygen therapy is started and gradually increased depending on the severity of the respiratory hypoxia.…”
Section: Oxygenation and Ventilationmentioning
confidence: 99%
“…( AIIMS/ ICMR-COVID-19, , American Psychiatric Association, & American Psychiatric Association, 2013 , Azhideh et al, 2020 , Andrade, 2011 Apr , Banerjee and Viswanath, 2020 , Bodnar et al, 2021 Apr , Boutron and Ravaud, 2018 , Chapnick, 2019 , Dewan and Gupta, 2016 Mar 1 , Hyland et al, 2020 , Kirkpatrick and Miller, 2013 , Lahiri and Ardila, 2020 Apr , Lewis and Smith, 1983 , Megahed and Ghoneim, 2020 , Mølhave, 2021 , Rehman et al, 2021 Jan , Sanchez-Alonso et al, 2020 Aug 1 , Upadhyaya and James, 2019 Apr 4 , World Health Organization, 2004 Dec 31 )…”
Section: Uncited Referencesmentioning
confidence: 99%